Ever since the start of the coronavirus COVID-19 global pandemic way back in December 2021, the world has been waiting on tenterhooks for a vaccine solution to its viral problems. During the pandemic the World Health Organisation (WHO) has repeatedly called for more developed countries to share vaccine doses with their lower income counterparts, but the call has for the most part landed on deaf ears.
As inequality seems on the rise around the world, it’s no surprise then that countries are keen to develop their own solution to the COVID-19 pandemic problem. While countries usually seen at the forefront of science and medicine such as the UK, Germany and the USA were quick to develop and distribute their own vaccine concoctions internationally, other countries with high population numbers such as India and China quickly followed behind in their vaccine development programmes.
The hunt for a vaccine has gone better and worse for some, with various vaccines being clinically tested at any one time. The Pfizer vaccine from the UK is one variation that caused global concern after it was linked to an increased chance of blood clots leading to death. With much conflicting information in circulation, many governments decided to stop use of the vaccine despite the increased risk of blood clots coming from getting the coronavirus itself.
A slow uptake in vaccines and overall vaccine hesitancy as a result of such incidences, as well as a growing concern from anti-vaxxers over the years that linked vaccines to autism in children, has caused a range of problems. From vaccine doses going to waste to a disastrous second wave in India, coronavirus continues to rage on around the world.
Cuba subsequently has been the latest country to develop its own vaccine. The Soberana 2 vaccine is currently in Phase 3 trials in Cuba and looks to be the country’s best hope at getting vaccinated so far.